Insulet Corporation in 2 stories
The narratives PODD currently appears in, with its side and exposure in each.
Bull side
1 story- Managed Care's Margin Machine Breaks
PODD in “Managed Care's Margin Machine Breaks”
FadingExposure: not rated yetRising utilization, tougher reimbursement and scrutiny of denials are shifting economics from insurers back to care providers.
Expanding diabetes treatment and coverage increase adoption of Insulet's recurring-revenue insulin-delivery systems.
Bear side
1 story- GLP-1 Eats Everything
PODD in “GLP-1 Eats Everything”
FadingExposure: not rated yetAppetite suppression as a macro variable.
Lower progression to insulin-dependent type 2 diabetes would constrain the incremental addressable market for Insulet's Omnipod pumps, although type 1 demand remains intact.